IGC Pharma Inc (IGC)
0.3561
0.00 (0.00%)
USD |
NYAM |
Nov 22, 13:22
IGC Pharma Total Assets (Quarterly): 10.37M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 10.37M |
| June 30, 2024 | 10.59M |
| March 31, 2024 | 9.902M |
| December 31, 2023 | 11.26M |
| September 30, 2023 | 16.51M |
| June 30, 2023 | 15.67M |
| March 31, 2023 | 17.18M |
| December 31, 2022 | 20.07M |
| September 30, 2022 | 21.96M |
| June 30, 2022 | 24.17M |
| March 31, 2022 | 26.83M |
| December 31, 2021 | 31.29M |
| September 30, 2021 | 33.84M |
| June 30, 2021 | 34.44M |
| March 31, 2021 | 35.87M |
| December 31, 2020 | 24.16M |
| September 30, 2020 | 26.35M |
| June 30, 2020 | 28.30M |
| March 31, 2020 | 28.98M |
| December 31, 2019 | 31.10M |
| September 30, 2019 | 32.89M |
| June 30, 2019 | 33.50M |
| March 31, 2019 | 34.46M |
| December 31, 2018 | 37.16M |
| September 30, 2018 | 16.55M |
| Date | Value |
|---|---|
| June 30, 2018 | 11.52M |
| March 31, 2018 | 10.85M |
| December 31, 2017 | 11.34M |
| September 30, 2017 | 9.992M |
| June 30, 2017 | 9.436M |
| March 31, 2017 | 11.28M |
| December 31, 2016 | 11.17M |
| September 30, 2016 | 18.86M |
| June 30, 2016 | 18.50M |
| March 31, 2016 | 18.86M |
| December 31, 2015 | 18.40M |
| September 30, 2015 | 18.82M |
| June 30, 2015 | 20.58M |
| March 31, 2015 | 20.33M |
| December 31, 2014 | 21.26M |
| September 30, 2014 | 21.19M |
| June 30, 2014 | 21.61M |
| March 31, 2014 | 17.73M |
| December 31, 2013 | 18.19M |
| September 30, 2013 | 18.54M |
| June 30, 2013 | 18.58M |
| March 31, 2013 | 19.25M |
| December 31, 2012 | 21.44M |
| September 30, 2012 | 24.22M |
| June 30, 2012 | 24.83M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
9.902M
Minimum
Mar 2024
35.87M
Maximum
Mar 2021
22.94M
Average
24.16M
Median
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 13.59M |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Protalix BioTherapeutics Inc | 61.56M |
| Palatin Technologies Inc | 3.415M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.992M |
| Shareholders Equity (Quarterly) | 7.377M |
| Debt to Equity Ratio | 0.0183 |
| Current Ratio | 1.517 |
| Net Debt Paydown Yield | 0.00% |